GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

$69.94 -1.96 (-2.73%)

Closing price 07/30/2026 04:00 PM Eastern

Extended Trading

$69.59 -0.35 (-0.50%)

As of 07/30/2026 07:55 PM Eastern

Compare

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 21 Analyst Ratings

Sell
1

Hold
10

Buy
10

Based on 21 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Hold." Out of the 21 analysts, 1 has given a sell rating, 10 have given a hold rating, and 10 have given a buy rating for GEHC.

Consensus Price Target

$77.45
10.74% Upside

According to the 21 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $77.45. The highest price target for GEHC is $98.00, while the lowest price target for GEHC is $14.00. The average price target represents a forecasted upside of 10.74% from the current price of $69.94.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GEHC Analyst Ratings Over Time

Type	Current Forecast 7/31/25 to 7/31/26	1 Month Ago 7/1/25 to 7/1/26	3 Months Ago 5/2/25 to 5/2/26	1 Year Ago 7/31/24 to 7/31/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	10 Buy rating(s)	10 Buy rating(s)	8 Buy rating(s)	8 Buy rating(s)
Hold	10 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$77.45	$80.20	$80.67	$88.55
Forecasted Upside	10.74% Upside	23.65% Upside	32.18% Upside	24.15% Upside
Consensus Rating	Hold	Moderate Buy	Hold	Moderate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GE HealthCare Technologies Stock vs. The Competition

Type	GE HealthCare Technologies	Medical Companies	Broader Market
Consensus Rating Score	2.43	2.30	2.53
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	10.74% Upside	987.35% Upside	13.21% Upside
News Sentiment Rating	Positive News See Recent GEHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/30/2026	Evercore 3 of 5 stars		Reiterated Rating	Outperform	$84.00	+21.58%
7/30/2026	Oppenheimer 3 of 5 stars	Suraj Kalia 2 of 5 stars	Reiterated Rating	Outperform
7/30/2026	Citigroup 4 of 5 stars	Joanne Wuensch 2 of 5 stars	Boost Target	Neutral	$69.00 ➝ $75.00	+4.31%
7/30/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$75.00 ➝ $85.00	+22.84%
7/29/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bednar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
7/29/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$75.00 ➝ $79.00	+11.59%
7/21/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold ➝ Strong Sell
7/17/2026	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Market Perform	$14.00	-77.87%
7/16/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Graham Doyle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$69.00 ➝ $67.00	+3.27%
7/8/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Market Perform	$70.00	+8.23%
Get the Latest News and Ratings for GEHC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.
6/23/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$80.00	+31.93%
6/8/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
5/19/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$95.00 ➝ $80.00	+28.92%
5/15/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C) ➝ Hold (C-)
5/1/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$95.00 ➝ $88.00	+44.24%
4/30/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$87.00 ➝ $78.00	+31.11%
4/30/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target		$90.00 ➝ $80.00	+32.31%
4/30/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$100.00 ➝ $90.00	+47.52%
4/30/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$105.00 ➝ $90.00	+47.52%
4/30/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$110.00 ➝ $98.00	+60.63%
4/30/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robbie Marcus Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$80.00 ➝ $65.00	+6.84%
4/29/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$80.00	+34.24%
2/4/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$80.00 ➝ $85.00	+2.93%
1/5/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Bijou Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$82.00 ➝ $92.00	+11.08%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:15 AM ET.

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, July 29, 2026. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

The current stock price is around $63, which may present a buying opportunity for investors looking for value in the healthcare technology sector.
GE HealthCare Technologies Inc. has demonstrated strong revenue growth, with a year-over-year increase of 7.4%, indicating a robust demand for its products and services.
The company has a solid return on equity of 20.46%, suggesting effective management and profitability, which can be attractive to investors seeking reliable returns.
With a market capitalization of approximately $28.58 billion, GE HealthCare Technologies Inc. is positioned as a significant player in the medical technology field, which may provide stability and growth potential.
The firm has a low debt-to-equity ratio of 0.95, indicating a balanced approach to financing that reduces financial risk for investors.

GE HealthCare Technologies
Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

The company recently reported earnings per share of $0.99, which fell short of analysts' expectations, potentially signaling challenges in meeting future growth targets.
GE HealthCare Technologies Inc. has a relatively low dividend yield of 0.2%, which may not be appealing to income-focused investors looking for higher returns from dividends.
The price-to-earnings (P/E) ratio of 15.03 suggests that the stock may be overvalued compared to its earnings, which could deter value investors.
With a beta of 0.72, the stock is less volatile than the market, which may limit potential gains during bullish market conditions.
The company has set its fiscal year 2026 guidance at 4.800-5.000 EPS, which may indicate slower growth expectations compared to previous periods.

GEHC Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $77.45, with a high forecast of $98.00 and a low forecast of $14.00.

21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last twelve months. There is currently 1 sell rating, 10 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GEHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GEHC, but not buy additional shares or sell existing shares.

According to analysts, GE HealthCare Technologies's stock has a predicted upside of 10.74% based on their 12-month stock forecasts.

Over the previous 90 days, GE HealthCare Technologies's stock had 2 upgrades and 2 downgrades by analysts.

GE HealthCare Technologies has been rated by research analysts at Argus, BMO Capital Markets, BTIG Research, Citigroup, Evercore, Hovde Group, Oppenheimer, Piper Sandler, Royal Bank Of Canada, The Goldman Sachs Group, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like GE HealthCare Technologies more than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.43 while the average consensus rating score for "medical" companies is 2.30. Learn more on how GEHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

This page (NASDAQ:GEHC) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

GEHC Analyst Ratings Over Time

GEHC Analyst Recommendations By Month

GEHC Price Targets by Month

GE HealthCare Technologies Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

GE HealthCare Technologies
Bull Case

GE HealthCare Technologies
Bear Case

GEHC Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

GEHC Analyst Ratings Over Time

GEHC Analyst Recommendations By Month

GEHC Price Targets by Month

GE HealthCare Technologies Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

GE HealthCare Technologies Bull Case

GE HealthCare Technologies Bear Case

GEHC Forecast - Frequently Asked Questions

What is GE HealthCare Technologies' forecast for 2026?

Should I buy or sell GE HealthCare Technologies stock right now?

Does GE HealthCare Technologies's stock price have much upside?

Has GE HealthCare Technologies been upgraded or downgraded by Wall Street analysts recently?

What analysts cover GE HealthCare Technologies?

Do Wall Street analysts like GE HealthCare Technologies more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

GE HealthCare Technologies
Bull Case

GE HealthCare Technologies
Bear Case